ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,503Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 1448

$406K Total Retail Price of All Prescriptions

Rank: 198 out of 1448

687 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 10,818 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METOPROLOL TARTRATE 1,519 1,426 1 9
DIGOXIN 929 879 10 2 13
BENAZEPRIL HCL 782 744 3 26
WARFARIN SODIUM 690 672 4 8
SIMVASTATIN 654 639 5 3
FUROSEMIDE 439 421 6 7
AMLODIPINE BESYLATE 385 378 7 2
ATORVASTATIN CALCIUM 371 338 8 4
CARVEDILOL 355 321 9 1
LISINOPRIL 339 312 10 5
HYDROCHLOROTHIAZIDE 311 293 11 18
LOSARTAN POTASSIUM 307 271 12 11
DIOVAN 280 244 13 15
CLOPIDOGREL 271 221 14 10
POTASSIUM CHLORIDE 246 240 15 19
LOVASTATIN 232 212 16 35
PLAVIX 223 191 17 14
BENICAR 153 153 18 50
NITROGLYCERIN PATCH 147 124 19 98
SOTALOL 127 127 20 40
MECLIZINE HCL 125 118 21 108
DIOVAN HCT 123 123 22 29
CLONIDINE HCL 120 120 23 45
AMITRIPTYLINE HCL 120 120 R 23 153
AMIODARONE HCL 117 116 25 22
TRIAMTERENE-HCTZ 103 103 26 55
LOSARTAN-HYDROCHLOROTHIAZIDE 102 101 27 38
METOPROLOL SUCCINATE 90 88 28 6
ZETIA 88 87 29 28
ATENOLOL 87 79 30 12
LIPITOR 82 78 31 30
VYTORIN 77 76 32 71
TRICOR 67 67 33 94
BENICAR HCT 64 62 34 84
HYDRALAZINE HCL 57 57 35 44
SPIRONOLACTONE 57 41 35 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.